Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Fixed Rate Borrowings and Property Purchase

15 May 2026 07:00

RNS Number : 4226E
Value and Indexed Prop Inc Tst PLC
15 May 2026
 

VALUE AND INDEXED PROPERTY INCOME TRUST PLC

 

FIXED RATE BORROWINGS AND PROPERTY PURCHASE

 

BORROWINGS

 

Value and Indexed Property Income Trust PLC (VIP) is pleased to announce the conversion of its undrawn £15 million Revolving Credit Facility, arranged in August 2025, to a Fixed Term Loan maturing on 31 March 2033. The loan was drawn down in full on 7 May 2026 at a fixed interest rate of 5.9% (1.3% above 7-year gilts) and will be used to fund new acquisitions. This brings VIP's average interest rate on all borrowings to 4.9% (of which 96% is at a fixed rate expiring in 2033). The loan to value ratio is 36%. 

 

NEW PURCHASE

 

Following the receipt of £5.44 million from the sale of 2,554,000 shares from Treasury in April 2026 at 213p, at a premium to the Company's latest published Net Asset Value per Share, VIP has bought a freehold cinema in the affluent commuter town of Esher in Surrey for £4.6 million, at a net initial yield of 9.0%, rising to an estimated 9.3% in July this year. This four screen cinema is let to Everyman Media Group Plc for a further 19.2 years, with annual RPI-linked rent reviews, subject to a collar and cap of 1% and 5%. 

 

Following completion of the purchase on 2 June, the portfolio's net initial yield will remain at 6.8% and the portfolio's WAULT (Weighted Average Unexpired Lease Term) will increase to 13.9 years to break from 13.6 years and 16.0 years to expiry from 15.8 years. 

 

Further information can be found here:

https://www.olimproperty.co.uk/value-and-indexed-property-income-trust.html

 

Enquiries:

OLIM Property Limited, Investment Manager

Tel: 020 7846 3252

Sarah.martin@olimproperty.co.uk

Matthew.oakeshott@olimproperty.co.uk

Louise.cleary@olimproperty.co.uk

 

Maven Capital Partners UK LLP

Company Secretary

Tel: 0141 306 7400

 

15 May 2026

 

Important information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the Market Abuse Regulations (EU) No. 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUSUNRNWUVAAR
Date   Source Headline
20th Dec 20247:00 amRNSTransaction in Own Shares
26th Nov 202411:29 amRNSHalf-year Report - Replacement
26th Nov 20247:00 amRNSHalf-year Report
25th Nov 20245:14 pmRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20245:19 pmRNSTransaction in Own Shares
18th Nov 20244:57 pmRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20245:05 pmRNSTransaction in Own Shares
12th Nov 20245:49 pmRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20245:13 pmRNSTransaction in Own Shares
15th Oct 20245:21 pmRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20244:55 pmRNSTransaction in Own Shares
7th Oct 20245:18 pmRNSTransaction in Own Shares
3rd Oct 202410:31 amRNSStatement re MAR
3rd Oct 202410:08 amRNSPortfolio Update and Half Year End Valuation
18th Sep 20249:38 amRNSDividend Declaration
9th Sep 20247:00 amRNSChange of AIFM
23rd Jul 202411:00 amRNSDirector/PDMR Shareholding
17th Jul 20243:22 pmRNSDirectorate Change
11th Jul 20241:13 pmRNSResult of AGM
20th Jun 20245:37 pmRNSTransaction in Own Shares
12th Jun 20247:00 amRNSAnnual Financial Report
29th Apr 20244:58 pmRNSTransaction in Own Shares
25th Apr 20245:01 pmRNSTransaction in Own Shares
24th Apr 20245:24 pmRNSTransaction in Own Shares - Replacement
24th Apr 20245:11 pmRNSTransaction in Own Shares
23rd Apr 20245:16 pmRNSTransaction in Own Shares
18th Apr 20244:56 pmRNSTransaction in Own Shares
15th Apr 20245:03 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20245:13 pmRNSTransaction in Own Shares
4th Apr 20244:59 pmRNSTransaction in Own Shares
4th Apr 202411:39 amRNSStatement re MAR
2nd Apr 20247:00 amRNSAcquisitions and Year End Portfolio Valuation
19th Mar 20245:01 pmRNSTransaction in Own Shares
18th Mar 20244:49 pmRNSTransaction in Own Shares
14th Mar 20244:54 pmRNSTransaction in Own Shares
11th Mar 20245:06 pmRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20244:49 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSDividend Declaration
6th Feb 20245:01 pmRNSTransaction in Own Shares
22nd Dec 202312:26 pmRNSHolding(s) in Company
21st Dec 20234:30 pmRNSDirector/PDMR Shareholding
20th Dec 202311:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.